T2	Participants 405 478	Emergency room/outpatient paediatric services of a tertiary care hospital
T3	Participants 489 677	Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9, were enrolled
T4	Participants 1069 1158	117 children (60 in montelukast group and 57 in placebo group) were enrolled in the study
T1	Participants 57 152	standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age
T5	Participants 1571 1643	standard therapy of inhaled bronchodilators and systemic glucocorticoids
T6	Participants 295 346	standard therapy in acute moderate to severe asthma
